PhaseV to Showcase Innovative Clinical Trial Solutions
PhaseV to Present at Major Healthcare and Technology Events
Exploring Machine Learning Solutions for Clinical Trial Optimization
PhaseV, known for its innovative role in clinical trial optimization using machine learning, has announced participation at several prominent industry events in the near future. As the field of clinical trials evolves, machine learning tools are becoming increasingly vital for drug developers who aim to enhance trial efficacy and navigate new complexities.
Upcoming Presentations by PhaseV Executives
Company leaders will be addressing crucial topics at various esteemed conferences, demonstrating the effectiveness of their advanced trial optimization platforms.
European Society For Medical Oncology (ESMO) Congress
PhaseV will present at the ESMO Congress from September 13–17 in Barcelona. This event highlights cutting-edge research in oncology.
- Presentation: 1342P: Efficacy of Pembrolizumab vs. Nivolumab Plus Ipilimumab in Metastatic NSCLC in Relation to PD-L1 and TMB Status
- Speakers: Walid Shalata, MD, and Dan Goldstaub, PhD
- Date/Time: Saturday, September 14
ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop
This workshop runs from September 25–27 in Rockville, MD, and is crucial for discussing regulatory challenges in biopharmaceutical statistics.
- Presentations:
- 3823: Comparative Analysis of Immunotherapy Alternatives in Non-Small-Cell Lung Cancer - Elad Berkman, CTO of PhaseV
- 3806: Model Guided Parameter Optimization for Complex Innovative Trial Designs - Tzviel Frostig, PhD
- Date/Time: Both on September 26 at 5:45pm EDT
Italian Tech Week
Another engaging event is the Italian Tech Week from September 25–27 in Turin, focusing on innovative technology in pharmaceutical development.
- Panel Topic: The Pharma of the Future: Robots, AI, and Adaptive Trials
- Speakers: Raviv Pryluk, Fred Manby, and Fred Parietti
- Moderator: Ileana Pirozzi
- Date/Time: September 25, 3:02–3:27pm CET
Bayesian Biostatistics Conference Bayes 2024
From October 23–25 in Rockville, PhaseV will discuss groundbreaking topics in Bayesian biostatistics.
- Presentations:
- To Bayes or Not to Bayes: Challenges in Designing Bayesian Adaptive Trials - Raviv Pryluk, PhD
- The Wolf Will Live with the Lamb: Enhancing Detection in Clinical Trials - Oshri Machluf
- Date/Times: Raviv on October 23 from 2:10–2:30pm EDT, Oshri on October 24 from 11:35–11:55am EDT
Innovation within PhaseV's Platforms
Since its inception, PhaseV's proprietary machine learning platform has transformed the landscape of clinical trials, affording researchers the ability to craft and adapt trial designs with greater efficiency. The technology empowers users with the capacity to analyze an extensive range of parameters swiftly, targeting optimal outcomes aligned with trial objectives.
Encouragingly, PhaseV also introduces its novel causal-ML pipeline that uncovers hidden signals within clinical data, thereby enhancing the understanding of treatment effects across diverse patient demographics. This offers researchers invaluable insights to refine subsequent trial designs, ultimately aiming to boost success rates.
About PhaseV
PhaseV leverages cutting-edge machine learning techniques to streamline clinical trial processes. The firm is committed to revolutionizing clinical trial methodologies to facilitate the equitable distribution of new treatments to patients in a quicker and more efficient manner. To learn more about their groundbreaking work, visit www.phaseVtrials.com and connect with them on LinkedIn.
Frequently Asked Questions
What is PhaseV?
PhaseV is an innovative company focused on using machine learning to optimize clinical trials, helping drug developers enhance trial outcomes.
What events will PhaseV be presenting at?
PhaseV will be presenting at the ESMO Congress, ASA Biopharmaceutical Workshop, Italian Tech Week, and the Bayesian Biostatistics Conference.
How does machine learning facilitate clinical trial design?
Machine learning empowers researchers to analyze numerous parameters swiftly, leading to optimal trial designs that meet specific objectives.
Who are some key speakers representing PhaseV?
Key speakers include CEO Raviv Pryluk, CTO Elad Berkman, and Data Scientist Oshri Machluf, who will showcase their insights and findings at the events.
Where can I learn more about PhaseV's technology?
More information about PhaseV’s innovative technology can be found on their official website at www.phaseVtrials.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Super Micro Computer Responds to Hindenburg's Allegations
- Jamie Foxx Brings Humor to BetMGM's 2024 Football Campaign
- Autonomous Cars Forecast: Growth to USD 43.44 Billion By 2032
- Investing Insights: Nvidia Versus Arm Holdings in AI Sector
- BoomerangFX Expands Innovative Solutions in Asia and Latin America
- Costco to Expand with Four New Locations by End of 2024
- Asia Pacific Wireless Earphones Market Expected to Thrive
- Cork Packaging Market Expected to Hit USD 2.7 Billion Growth
- MICE Industry Expected to Reach $1,337 Billion by 2033
- Packaging Automation Market Growth Driven by E-commerce Boom
- Tiny Traveler Unveils Advanced AI Baby Monitor for Parents
- Portable Projector Market Growth Projections: $2.1 Billion by 2029
- HomeSafe Alliance Achieves Milestone Of 100 Military Moves
- Drew Ysseldyke Elevated to President & CEO of Grand River Bank
- Innovative Wireless Charging Technology Utilizing RF Signals
- Eton Solutions Unveils EtonGPT™, Revolutionary AI for Family Offices
- Proteomics Market Projected to Exceed $60 Billion by 2029
- Peraton Names Steve Schorer New CEO to Lead Growth Strategy
- Exploring the Event Logistics Market Growth to USD 87.8 Billion
- Berkshire Hathaway Hits $1 Trillion, What's Next for Investors?
- How a Single Tesla Deal Elevated a Family's Fortune to $800 Million
- Education ERP Market Growth Projected to USD 75.84 Billion
- UK Home Prices Expected to Rise, Boosting First-Time Buyer Affordability
- UC Asset LP Announces Management-Driven Stock Buyback Plan
- US Dollar Index Emerges as Key Factor for European Markets
Recent Articles
- Status of Audit for Aktsiaselts Silvano Fashion Group Revealed
- Former Central Bank Governor Riad Salameh Faces Arrest Over Fraud
- Airlines Adjust Operations Amid Middle East Tensions
- US Dollar Index Emerges as Key Factor for European Markets
- IRS Audit Rates: Insights on Wealthy Taxpayer Scrutiny
- Cambridge Judge Launches Family Business Leadership Programme
- Connected Agriculture Market Expected to Reach USD 16.88 Billion
- Growth Projections in Global Industrial Distribution Market
- SS Innovations' First Mantra Surgical System Sale in Latin America
- Simtra BioPharma Solutions Welcomes Dr. Mike Schaefers
- Fleet Management Software Market Growth to USD 93.17 Billion
- Semnur Pharmaceuticals and Denali Capital to Merge for Growth
- Huddle House Launches MVP Waffle Tacos to Delight Guests
- Flight Adventure Park Launches Annual 'Soar For A Cause' Event
- Cerro de Pasco Resources Completes Strategic Mine Sale
- UMMC Partners with Fiducius for Financial Wellness Initiative
- Is Walgreens Boots Alliance Stock a Smart Investment Now?
- Vaxcyte's VAX-31 Vaccine Shows Promising Phase 1/2 Study Results
- Protalix BioTherapeutics Eliminates Debt with Note Repayment
- Castellum, Inc. Appoints Drew Merriman New Chief Operating Officer
- Embecta Secures FDA Clearance for Diabetes Patch Pump
- Vow ASA Insights: Recent Insider Trading Activity Reported
- Find Comfort and Assurance This Fall at Gate of Heaven
- Market Trends: Insights from a Leading Financial Strategist
- Bitcoin's Recent Surge: Economic Data and Fed Decisions Ahead